JOHNSON & JOHNSON Treasury Stock 2007-2026 | JNJ
Beta
What is treasury stock?
Treasury stock represents shares that were previously issued and later repurchased by the company, reducing total stockholders' equity.
What is JOHNSON & JOHNSON's current treasury stock?
JOHNSON & JOHNSON (JNJ) annual treasury stock for 2025 was $75.62B, a 0.07% decline from 2024. JOHNSON & JOHNSON treasury stock for the quarter ending March 29, 2026 was $76.26B.
What was JOHNSON & JOHNSON's treasury stock in 2024?
JOHNSON & JOHNSON annual treasury stock for 2024 was $75.68B, a 0.02% increase from 2023.
What was JOHNSON & JOHNSON's treasury stock in 2023?
JOHNSON & JOHNSON annual treasury stock for 2023 was $75.66B, a 93.51% increase from 2022.
What is JOHNSON & JOHNSON's 4-year treasury stock CAGR?
JOHNSON & JOHNSON treasury stock grew at a compound annual growth rate (CAGR) of 18.39% from FY2021 to FY2025, going from $38.49B to $75.62B over 4 years.
Treasury Stock History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+14.5%
FY2019
$38.42B
→
FY2025
$75.62B
07081011121314161718192122232425
5 years selected
Treasury Stock History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $75.62B | -0.1% | 10-K |
| FY2024 | $75.68B | +0.0% | 10-K |
| FY2023 | $75.66B | +93.5% | 10-K |
| FY2022 | $39.10B | +1.6% | 10-K |
| FY2021 | $38.49B | +0.2% | 10-K |
| FY2019 | $38.42B | +11.8% | 10-K |
| FY2018 | $34.36B | +8.9% | 10-K |
| FY2017 | $31.55B | +39.1% | 10-K |
| FY2016 | $22.68B | +14.0% | 10-K |
| FY2014 | $19.89B | +26.7% | 10-K |
| FY2013 | $15.70B | -15.0% | 10-K |
| FY2012 | $18.48B | -11.1% | 10-K |
| FY2011 | $20.78B | +5.1% | 10-K |
| FY2010 | $19.78B | +3.9% | 10-K |
| FY2008 | $19.03B | +32.3% | 10-K |
| FY2007 | $14.39B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →